214 results on '"Uchida, Yoshihito"'
Search Results
2. Evaluation of an immunochromatography-based rapid antigen test, Inspecter Kowa® SARS-CoV-2, using saliva specimens for the detection of SARS-CoV-2
3. Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.
4. Long‐term effects of ipragliflozin and pioglitazone on metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow‐up of a randomized, 24 week, active‐controlled trial: Effect of ipragliflozin in MASLD
5. Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria
6. 拠点病院以外の肝疾患専門医療機関における院内肝炎ウイルス陽性者対策調査
7. Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19
8. Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma.
9. 肝疾患診療連携拠点病院における肝炎医療コーディネーターの現状(第2報)
10. Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
11. NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir
12. Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
13. Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir
14. Portal venous blood flows determine liver function in patients with decompensated cirrhosis due to HCV infection receiving successful sofosbuvir/velpatasvir therapy
15. Sequential therapy consisting of glucocorticoid infusions followed by granulocyte–monocyte absorptive apheresis in patients with severe alcoholic hepatitis
16. Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct‐acting antivirals
17. “Reversi‐type virologic failure” involved in the development of non‐structural protein 5A resistance‐associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline
18. Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis
19. Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies
20. Significance of variants associated with resistance to NS5A inhibitors in Japanese patients with genotype 1b hepatitis C virus infection as evaluated using cycling-probe real-time PCR combined with direct sequencing
21. Two Cases of Intraabdominal Bleeding Caused by Hepatocellular Carcinoma Rupture Soon after the Initiation of Chemotherapy with Lenvatinib
22. Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices
23. Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study
24. Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog
25. Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation
26. Severe Hepatotoxicity Associated With Asunaprevir and Daclatasvir in Chronic Hepatitis C
27. Drug-induced immunoallergic hepatitis during combination therapy with daclatasvir and asunaprevir
28. SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV
29. Balloon-occluded retrograde transvenous obliteration (B-RTO) for the treatment of hepatic encephalopathy and liver failure in patients with cirrhosis: P-434
30. Two cases with advanced gastric cancer showing massive bleeding successfully treated by transcatehter arterial embolization: P-312
31. Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient
32. Esophageal function worsens with long duration of diabetes
33. Present status of hepatitis medical care coordinators in regional core centers in Japan
34. A Novel HBV Genotype Developing as a Consequence of Recombination of HBV Genotypes B and H: 499
35. Nationwide Prospective Survey to Evaluate the Significance of Viral Reactivation in Patients with Prior HBV Infection Receiving Immunosuppressive or Anticancer Agents Other than Rituximab in Japan: 467
36. Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis
37. Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis
38. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate
39. Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome
40. Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus
41. Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate
42. Abstracts of selected papers presented at the 79th general meeting of the Japanese Society of Gastroenterology March 29–31, 1993, Kyoto, Japan
43. Is the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients?
44. Role of energy metabolism in drug-induced acute gastric mucosal injuries in humans
45. A case of genotype‐3b hepatitis C virus in which the whole genome was successfully analyzed using third‐generation nanopore sequencing
46. Deteriorated outcome of recent patients with acute liver failure and late‐onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan
47. Sucrose permeability as a means of detecting diseases of the upper digestive tract
48. Clinical comparisons between two subsets of gastric antral vascular ectasia
49. Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy
50. The effect of ciclesonide on the airflow obstruction in the small airways and asthma-related quality of life in patients with asthma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.